SELLAS Life Sciences Group, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
SELLAS Life Sciences Group, Inc. (SLS) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $0 for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-11-09
- SELLAS Life Sciences Group, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was $25.00K.
- SELLAS Life Sciences Group, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$7.00K.
- SELLAS Life Sciences Group, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$18.00K.
- SELLAS Life Sciences Group, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was $0.00.
- SELLAS Life Sciences Group, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$6.00K.
- SELLAS Life Sciences Group, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$354.00K.
- SELLAS Life Sciences Group, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$2.47M, a 170.79% decline from fiscal 2013.
- SELLAS Life Sciences Group, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was $3.49M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-09-30 | $25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $18.00K derived: sum of 2 quarters · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | $0.00 derived: sum of 4 quarters · filed 2017-11-09 |
| 2017-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$25.00K 10-Q · filed 2017-08-14 | -$25.00K derived: sum of 3 quarters · filed 2017-08-14 | -$25.00K derived: sum of 4 quarters · filed 2017-11-09 |
| 2017-03-31 | -$18.00K 10-Q · filed 2017-05-10 | -$18.00K derived: sum of 2 quarters · filed 2017-05-10 | -$18.00K derived: sum of 3 quarters · filed 2017-11-09 | -$18.00K derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $0.00 derived: sum of 3 quarters · filed 2017-11-09 | -$6.00K 10-K · filed 2017-03-15 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | -$6.00K 10-Q · filed 2017-11-09 | -$78.00K derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$6.00K 10-Q · filed 2017-08-14 | -$78.00K derived: sum of 3 quarters · filed 2017-08-14 | -$326.00K derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | -$6.00K 10-Q · filed 2017-05-10 | -$78.00K derived: sum of 2 quarters · filed 2017-05-10 | -$326.00K derived: sum of 3 quarters · filed 2017-05-10 | -$342.00K derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | -$72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$320.00K derived: sum of 2 quarters · filed 2017-03-15 | -$336.00K derived: sum of 3 quarters · filed 2017-03-15 | -$354.00K 10-K · filed 2017-03-15 |
| 2015-09-30 | -$248.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$264.00K derived: sum of 2 quarters · filed 2016-11-09 | -$282.00K 10-Q · filed 2016-11-09 | -$391.00K derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | -$16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$34.00K 10-Q · filed 2016-08-09 | -$143.00K derived: sum of 3 quarters · filed 2017-03-15 | |
| 2015-03-31 | -$18.00K 10-Q · filed 2016-05-10 | -$127.00K derived: sum of 2 quarters · filed 2017-03-15 | ||
| 2014-12-31 | -$109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$2.47M 10-K · filed 2017-03-15 | ||
| 2014-09-30 | -$2.36M 10-Q · filed 2015-11-09 | |||
| 2013-12-31 | $3.49M 10-K/A · filed 2016-04-15 | |||
| 2012-12-31 | $0.00 8-K · filed 2015-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |